The Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) are requesting comments on how group [...] …
Year: 2024
The leading advocacy group for pharmaceutical manufacturers recently published an advertorial in the Washington Post that highlights a range of [...] …
Baptist Health of Alabama sued Humana in federal court over the lack of repayment by the company’s Medicare Advantage (MA) [...] …
If House Republicans maintain control of the chamber after the November elections, several senior members will likely vie to chair [...] …
The leading drugmaker advocacy group issued a data-linked map that aims to highlight the extent of contract pharmacy usage by [...] …
![img](https://340breport.com/wp-content/uploads/2023/03/340B-expert-tip-logo-final.png)
SPONSORED CONTENT
![img](https://340breport.com/wp-content/uploads/2023/03/340B-expert-tip-sidearrow-logo-final.png)
TIP: Ensure your organization complies with the new 340B billing modifier requirements effective in 2024 and 2025.
An influential Republican congressman yesterday told a gathering of health center leaders that more 340B hospital transparency was needed to [...] …
The Virginia state senate last Friday unanimously passed a bill that would prohibit drugmaker 340B contract pharmacy restrictions in the [...] …
New 340B provider reporting requirements were included in recently proposed legislation from a Connecticut state health agency, as part of [...] …
A key committee in the Oregon state house could vote tomorrow on a bill that would prohibit drugmaker 340B contract [...] …